Science Strategic Acquisition Alpha Corp (SSAA)
$10.05
$0.00 (0.00%)As on 21-Dec-2022 09:30EDT
Market cap
$390 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
25.1
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$10 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-161.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$20.8
-
Face value
--
-
Shares outstanding
31,050,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Science Strategic Acquisition Alpha Corp (SSAA)
| 3.1 | 0.2 | 1.9 | 2.9 | -- | -65.9 | -- |
|
BSE Sensex*
| -9.4 | 1.8 | 0.0 | -5.8 | 6.6 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Science Strategic Acquisition Alpha Corp (SSAA)
|
10.1 | 390.1 | 0.0 | 166.8 | -- | -- | 25.1 | 1.3 |
| 10.1 | 377.3 | 0.0 | 3,350,349.3 | -- | -- | 41.9 | 1.3 | |
| 10.1 | 352.0 | 0.0 | 4.8 | -- | -- | 77.5 | 1.3 | |
| 10.0 | 687.5 | 0.0 | 17.8 | -- | -- | 50 | 1.3 | |
| 10.0 | 576.2 | 0.0 | 15.6 | -- | -- | 29.5 | 1.3 | |
| 10.0 | 343.8 | 0.0 | 6.5 | -- | -- | 10.4 | 1.3 | |
| 10.1 | 522.4 | 0.0 | 32.0 | -- | -- | 48.1 | 1.3 | |
| 10.1 | 362.6 | 0.0 | 10.4 | -- | -- | 34.8 | 1.3 | |
| 10.1 | 870.3 | 0.0 | 35.8 | -- | -- | 31.5 | 1.3 | |
| 10.1 | 390.9 | 0.0 | 10.8 | -- | -- | 14.8 | 0.0 |
Shareholding Pattern
View DetailsAbout Science Strategic Acquisition Alpha Corp (SSAA)
Science Strategic Acquisition Corp. Alpha does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the... direct-to-consumer (D2C) brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California. Read more
-
Founder, CEO & Chairman
Mr. Michael Gwynne Jones
-
Founder, CEO & Chairman
Mr. Michael Gwynne Jones
-
Headquarters
Santa Monica, CA
-
Website
FAQs for Science Strategic Acquisition Alpha Corp (SSAA)
What is the current share price of Science Strategic Acquisition Alpha Corp (SSAA) Today?
The share price of Science Strategic Acquisition Alpha Corp (SSAA) is $10.05 (NASDAQ) as of 21-Dec-2022 09:30 EDT. Science Strategic Acquisition Alpha Corp (SSAA) has given a return of 2.87% in the last 1 years.
What is the current PB & PE ratio of Science Strategic Acquisition Alpha Corp (SSAA)?
The P/E ratio of Science Strategic Acquisition Alpha Corp (SSAA) is 25.13 times as on 20-Jan-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
0.49
|
-3.84
|
|
2020
|
--
|
--
|
|
2021
|
0.49
|
-3.84
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Science Strategic Acquisition Alpha Corp (SSAA)?
The 52-week high and low of Science Strategic Acquisition Alpha Corp (SSAA) are Rs -- and Rs -- as of 19-Jun-2026.
What is the market cap of Science Strategic Acquisition Alpha Corp (SSAA)?
Science Strategic Acquisition Alpha Corp (SSAA) has a market capitalisation of $ 390 Mln as on 20-Jan-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Science Strategic Acquisition Alpha Corp (SSAA)?
Before investing in Science Strategic Acquisition Alpha Corp (SSAA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.